CME Group Inc. (NASDAQ:CME) insider Hilda Harris Piell sold 714 shares of the stock in a transaction dated Wednesday, September 6th. The shares were sold at an average price of $129.00, for a total value of $92,106.00. Following the transaction, the insider now directly owns 28,844 shares in the company, valued at approximately $3,720,876. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

CME Group Inc. (NASDAQ CME) traded up 1.83% during mid-day trading on Friday, reaching $128.04. The company’s stock had a trading volume of 1,034,854 shares. The company has a 50 day moving average of $124.85 and a 200-day moving average of $121.77. The stock has a market cap of $43.52 billion, a PE ratio of 26.14 and a beta of 0.72. CME Group Inc. has a 52-week low of $98.95 and a 52-week high of $129.31.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share for the quarter, topping analysts’ consensus estimates of $1.20 by $0.03. The firm had revenue of $925 million for the quarter, compared to the consensus estimate of $931.05 million. CME Group had a return on equity of 7.61% and a net margin of 46.05%. The business’s revenue was up 2.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.14 earnings per share. Equities analysts forecast that CME Group Inc. will post $4.81 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, September 25th. Shareholders of record on Friday, September 8th will be given a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 2.06%. The ex-dividend date of this dividend is Thursday, September 7th. CME Group’s dividend payout ratio (DPR) is presently 53.99%.

COPYRIGHT VIOLATION WARNING: “Hilda Harris Piell Sells 714 Shares of CME Group Inc. (CME) Stock” was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another site, it was copied illegally and reposted in violation of U.S. & international copyright laws. The correct version of this article can be accessed at https://www.thecerbatgem.com/2017/09/09/hilda-harris-piell-sells-714-shares-of-cme-group-inc-cme-stock.html.

Hedge funds and other institutional investors have recently made changes to their positions in the business. RMB Capital Management LLC increased its position in CME Group by 3.1% during the first quarter. RMB Capital Management LLC now owns 114,834 shares of the financial services provider’s stock worth $13,642,000 after buying an additional 3,501 shares during the last quarter. Thrivent Financial For Lutherans grew its position in shares of CME Group by 5.6% in the first quarter. Thrivent Financial For Lutherans now owns 12,500 shares of the financial services provider’s stock valued at $1,485,000 after purchasing an additional 660 shares during the last quarter. Viking Fund Management LLC grew its position in shares of CME Group by 3.6% in the second quarter. Viking Fund Management LLC now owns 29,000 shares of the financial services provider’s stock valued at $3,632,000 after purchasing an additional 1,000 shares during the last quarter. Janus Capital Management LLC grew its position in shares of CME Group by 4.7% in the first quarter. Janus Capital Management LLC now owns 5,609,151 shares of the financial services provider’s stock valued at $666,367,000 after purchasing an additional 253,258 shares during the last quarter. Finally, Wells Fargo & Company MN grew its position in shares of CME Group by 25.5% in the second quarter. Wells Fargo & Company MN now owns 4,379,568 shares of the financial services provider’s stock valued at $548,496,000 after purchasing an additional 889,217 shares during the last quarter. 82.66% of the stock is currently owned by hedge funds and other institutional investors.

CME has been the topic of a number of analyst reports. Jefferies Group LLC reissued a “buy” rating and set a $128.00 price objective on shares of CME Group in a report on Monday, July 10th. Deutsche Bank AG reissued a “buy” rating and set a $133.00 price objective (down previously from $134.00) on shares of CME Group in a report on Monday, May 15th. UBS AG reissued a “buy” rating and set a $135.00 price objective (up previously from $134.00) on shares of CME Group in a report on Wednesday. Keefe, Bruyette & Woods reissued a “hold” rating and set a $127.00 price objective on shares of CME Group in a report on Friday, July 14th. Finally, Citigroup Inc. initiated coverage on CME Group in a report on Wednesday, July 12th. They set a “buy” rating and a $140.00 price objective on the stock. One analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the company’s stock. CME Group currently has a consensus rating of “Buy” and a consensus target price of $132.56.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Receive News & Stock Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related stocks with our FREE daily email newsletter.